ArticleFrontiers in medicine2026
Construction and internal cohort verification of clinical-imaging-based nomogram for early diagnosis in Takayasu arteritis.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Takayasu arteritis (TAK) is a chronic large-vessel vasculitis. This study aimed to develop and internally validate a nomogram model integrating clinical indicators, conventional imaging features, and radiomics features for the early diagnosis of TAK. Methods: A total of 356 patients suspected of having TAK in our hospital were retrospectively included. They were randomly divided into a training set ( Results: In the training set, 75 cases (30.12%) were diagnosed with early-stage TAK, and in the validation set, 32 cases (29.91%) were diagnosed. There were no statistically significant differences in the incidence of TAK and clinical characteristics between the two groups ( Conclusion: This study successfully constructed and validated a comprehensive nomogram model, which can provide individualized and non-invasive risk assessment for the early diagnosis of TAK and contribute to clinical decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.